IRIS Accounts Production v24.2.0.383 11906655 director 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh119066552023-03-31119066552024-03-31119066552023-04-012024-03-31119066552022-03-31119066552022-04-012023-03-31119066552023-03-3111906655ns15:EnglandWales2023-04-012024-03-3111906655ns14:PoundSterling2023-04-012024-03-3111906655ns10:Director12023-04-012024-03-3111906655ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3111906655ns10:SmallEntities2023-04-012024-03-3111906655ns10:AuditExemptWithAccountantsReport2023-04-012024-03-3111906655ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3111906655ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3111906655ns10:FullAccounts2023-04-012024-03-3111906655ns10:OrdinaryShareClass12023-04-012024-03-3111906655ns10:RegisteredOffice2023-04-012024-03-3111906655ns5:CurrentFinancialInstruments2024-03-3111906655ns5:CurrentFinancialInstruments2023-03-3111906655ns5:ShareCapital2024-03-3111906655ns5:ShareCapital2023-03-3111906655ns5:RetainedEarningsAccumulatedLosses2024-03-3111906655ns5:RetainedEarningsAccumulatedLosses2023-03-3111906655ns5:FurnitureFittings2023-03-3111906655ns5:ComputerEquipment2023-03-3111906655ns5:FurnitureFittings2023-04-012024-03-3111906655ns5:ComputerEquipment2023-04-012024-03-3111906655ns5:FurnitureFittings2024-03-3111906655ns5:ComputerEquipment2024-03-3111906655ns5:FurnitureFittings2023-03-3111906655ns5:ComputerEquipment2023-03-3111906655ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 11906655 (England and Wales)















TTR MEDTECH CONSULTANCY LIMITED

Unaudited Financial Statements for the Year Ended 31 March 2024






TTR MEDTECH CONSULTANCY LIMITED (REGISTERED NUMBER: 11906655)






Contents of the Financial Statements
for the year ended 31 March 2024




Page

Company Information 1

Accountants' Report 2

Balance Sheet 3

Notes to the Financial Statements 4 to 5


TTR MEDTECH CONSULTANCY LIMITED

Company Information
for the year ended 31 March 2024







Director: T Tomic-Reisel





Registered office: 5 Sansome Drive
Hinckley
Leicestershire
LE10 0YJ





Registered number: 11906655 (England and Wales)





Accountants: Cooper Parry Advisory Limited
CUBO Birmingham
3rd Floor
Two Chamberlain Square
Birmingham
West Midlands
B3 3AX

Accountants' Report to the Director
on the Unaudited Financial Statements of
TTR Medtech Consultancy Limited

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Statement of Comprehensive Income and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of TTR Medtech Consultancy Limited for the year ended 31 March 2024 which comprise the Statement of Income and Retained Earnings, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

This report is made solely to the director of TTR Medtech Consultancy Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of TTR Medtech Consultancy Limited and state those matters that we have agreed to state to the director of TTR Medtech Consultancy Limited in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its director for our work or for this report.

It is your duty to ensure that TTR Medtech Consultancy Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of TTR Medtech Consultancy Limited. You consider that TTR Medtech Consultancy Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of TTR Medtech Consultancy Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Cooper Parry Advisory Limited
CUBO Birmingham
3rd Floor
Two Chamberlain Square
Birmingham
West Midlands
B3 3AX


20 September 2024

TTR MEDTECH CONSULTANCY LIMITED (REGISTERED NUMBER: 11906655)

Balance Sheet
31 March 2024

2024 2023
Notes £    £    £    £   
Fixed assets
Tangible assets 4 975 1,397

Current assets
Cash at bank 103,336 67,699

Creditors
Amounts falling due within one year 5 25,313 25,422
Net current assets 78,023 42,277
Total assets less current liabilities 78,998 43,674

Capital and reserves
Called up share capital 6 100 100
Retained earnings 78,898 43,574
Shareholders' funds 78,998 43,674

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 September 2024 and were signed by:





T Tomic-Reisel - Director


TTR MEDTECH CONSULTANCY LIMITED (REGISTERED NUMBER: 11906655)

Notes to the Financial Statements
for the year ended 31 March 2024

1. Statutory information

TTR Medtech Consultancy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Tangible fixed assets are initially recognised at cost less accumulated depreciation and impairment.

Depreciation is provided at the following annual rates to write off each asset over its estimated useful life.

Fixtures and fittings - 20% on cost

Computer equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Debtors and creditors receivable/payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

3. Employees and directors

The average number of employees during the year was 1 (2023 - 1 ) .

TTR MEDTECH CONSULTANCY LIMITED (REGISTERED NUMBER: 11906655)

Notes to the Financial Statements - continued
for the year ended 31 March 2024

4. Tangible fixed assets
Fixtures
and Computer
fittings equipment Totals
£    £    £   
Cost
At 1 April 2023 1,115 1,132 2,247
Additions 167 - 167
At 31 March 2024 1,282 1,132 2,414
Depreciation
At 1 April 2023 192 658 850
Charge for year 306 283 589
At 31 March 2024 498 941 1,439
Net book value
At 31 March 2024 784 191 975
At 31 March 2023 923 474 1,397

5. Creditors: amounts falling due within one year
2024 2023
£    £   
Corporation Tax 18,242 18,940
Social security and other taxes 255 131
VAT 4,631 4,367
Directors' current accounts 208 7
Accruals and deferred income 1,977 1,977
25,313 25,422

6. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

7. Related party disclosures

At the reporting date an amount of £208 (2023: £7) was repayable to the Director of the company.

8. Ultimate controlling party

The ultimate controlling party is T Tomic-Reisel.